Syndax Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Syndax Pharmaceuticals Inc
TickerSNDX
CIK #0001395937
CUSIP87164F105
SectorLife Sciences - Pharmaceutical Preparations
Address460 Totten Pond Road Suite 650, Waltham, MA 02451
Source [EDGAR]
CIK Filing 2011 - 2025
[0001395937] 10-K
[0001395937] 10-Q
[0001395937] 3
[0001395937] 4
[0001395937] 8-K
[0001395937] D
[0001395937] SC 13D
[0001395937] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2025-08-18] 0.0
Goldman Sachs Group Inc Syndax Pharmaceuticals Inc [2025-02-12] 0.0
Morgan Stanley Syndax Pharmaceuticals Inc [2025-02-05] 0.0
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2025-01-22] 0.0
Kynam Capital Management LP Syndax Pharmaceuticals Inc [2024-02-14] 6.67
Vanguard Group Inc Syndax Pharmaceuticals Inc [2024-02-13] 5.11
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2023-10-31] 4.5
Wellington Management Group LLP Syndax Pharmaceuticals Inc [2023-01-10] 11.72
Nantahala Capital Management LLC Syndax Pharmaceuticals Inc [2022-02-14] 5.8
Frazier Life Sciences Public Fund LP Syndax Pharmaceuticals Inc [2021-12-23] 3.2
Adage Capital Partners GP LLC Syndax Pharmaceuticals Inc [2021-05-10] 5.6
Access Industries Holdings LLC Syndax Pharmaceuticals Inc [2021-05-03] 5.56
BlackRock Inc Syndax Pharmaceuticals Inc [2021-02-02] 5.0
Avidity Partners Management LP Syndax Pharmaceuticals Inc [2020-11-04] 6.7
Boxer Capital LLC Syndax Pharmaceuticals Inc [2020-05-11] 0.0
Access Industries Holdings LLC Syndax Pharmaceuticals Inc [2019-10-09] 6.1
Adage Capital Partners GP LLC Syndax Pharmaceuticals Inc [2019-04-08] 5.72
BlackRock Inc Syndax Pharmaceuticals Inc [2019-02-08] 6.3
683 Capital Management LLC Syndax Pharmaceuticals Inc [2018-11-29] 5.0
Biotechnology Value Fund L P Syndax Pharmaceuticals Inc [2017-11-14] 3.9
MPM BioVentures IV QP LP Syndax Pharmaceuticals Inc [2017-02-09] 0.9
BlackRock Inc Syndax Pharmaceuticals Inc [2017-01-30] 8.0
Domain Partners VIII LP Syndax Pharmaceuticals Inc [2017-01-09] 4.2
Wellington Management Group LLP Syndax Pharmaceuticals Inc [2016-09-12] 11.0
FMR LLC Syndax Pharmaceuticals Inc [2016-04-11] 0.0
Form 3/4/5 Filer 2011 - 2025
Podlesak Dennis
Syndax Pharmaceuticals Inc
Goldan Keith A.
Metzger Michael A
Huber Martin H. Jr.
Botwood Nicholas A.J.
Katkin Keith
Gallagher Neil
Meury William
Rizo Aleksandra
Jarrett Jennifer
Legault Pierre
Morrison Briggs
Ordentlich Peter
Nolte Alexander
Madigan Catherine
Sabus Steve M
Meyers Michael L.
Egros Fabrice
Karydas Daphne
Shea Richard P
BVF Partners OS Ltd.
Lampert Mark N
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF Partners L P/IL
Biotechnology Value Trading Fund OS LP
BVF Inc/IL
Evnin Luke
Chen Henry
Sledge George W. Jr.
Royston IVOR
Kamdar Kim P.
Scopa James Paul
Foley Todd
MPM BioVentures IV GmbH & Co. Beteiligungs KG
MPM BioVentures IV LLC
Kailian Vaughn M
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV Strategic Fund, L.P.
Gadicke Ansbert
MPM BioVentures IV GP LLC
MPM BioVentures IV QP LP
Blair James C
Treu Jesse I
Vitullo Nicole
DP VIII Associates, L.P.
Dovey Brian H
Halak Brian K
DP VI Associates, L.P.
Domain Partners VI, L.P.
Domain Partners VIII, L.P.
Shah Nimesh
Domain Associates
Shaw Allan
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 9,828,330 10,453,624
Kynam Capital Management LP [2025-06-30] SOLE 8,520,000 8,520,000
Goldman Sachs Group Inc [2025-06-30] DFND 5,707,703 5,738,287
Vanguard Group Inc [2025-06-30] SOLE 0 4,846,493
Eversept Partners LP [2025-06-30] SOLE 4,065,355 4,065,355
Bank of America Corp /DE/ [2025-06-30] DFND 12,573 3,838,872
State Street Corp [2025-06-30] DFND 3,237,385 3,442,752
Stempoint Capital LP [2025-06-30] SOLE 2,092,432 2,372,634
Franklin Resources Inc [2025-06-30] DFND 2,359,543 2,359,677
Point72 Asset Management LP [2025-06-30] DFND 0 2,127,467
Catalio Capital Management LP [2025-06-30] SOLE 2,104,512 2,104,512
Kingdon Capital Management LLC [2025-06-30] DFND 2,100,000 2,100,000
Geode Capital Management LLC [2025-06-30] DFND 2,049,350 2,049,350
Assenagon Asset Management S.A. [2025-06-30] SOLE 2,039,987 2,039,987
Woodline Partners LP [2025-06-30] SOLE 1,892,751 1,892,751
Caption Management LLC [2025-06-30] SOLE 1,764,771 1,764,771
Qube Research & Technologies Ltd [2025-06-30] SOLE 1,665,916 1,665,916
Millennium Management LLC [2025-06-30] SOLE 1,598,613 1,598,613
Sphera Funds Management Ltd [2025-06-30] DFND 1,571,564 1,571,564
Sofinnova Investments Inc [2025-06-30] SOLE 1,524,440 1,524,440
BNP Paribas Asset Management Holding S.A. [2025-06-30] DFND 0 1,445,440
UBS Group AG [2025-06-30] DFND 1,429,853 1,435,415
Adage Capital Partners GP LLC [2025-06-30] SOLE 1,432,440 1,432,440
Eventide Asset Management LLC [2025-06-30] SOLE 1,414,081 1,414,081
Aisling Capital Management LP [2025-06-30] SOLE 1,316,806 1,316,806
Soleus Capital Management LP [2025-06-30] SOLE 1,092,110 1,092,110
ProSight Management LP [2025-06-30] SOLE 1,079,673 1,079,673
Granahan Investment Management LLC [2025-06-30] SOLE 857,207 991,388
Parkman Healthcare Partners LLC [2025-06-30] SOLE 867,813 867,813
Morgan Stanley [2025-06-30] DFND 812,990 849,236
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com